Covered recipient · General Payments record
SANDRA A MAZUR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,433.47
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $656.53 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $247.76 | 6 |
| Novo Nordisk AS | $193.87 | 10 |
| ABBVIE INC. | $124.01 | 5 |
| Acerta Pharma LLC | $29.78 | 1 |
| Abbott Laboratories | $17.12 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.79 | 1 |
| Currax Pharmaceuticals LLC | $13.95 | 1 |
| Lilly USA, LLC | $13.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.12 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125140271 | CMS |
| ABBVIE INC. | $34.89 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104990903 | CMS |
| ABBVIE INC. | $30.84 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104990905 | CMS |
| ABBVIE INC. | $14.83 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104990907 | CMS |
| ABBVIE INC. | $18.60 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104990909 | CMS |
| ABBVIE INC. | $24.85 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104990911 | CMS |
| Amgen Inc. | $25.88 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117321860 | CMS |
| Amgen Inc. | $19.60 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117321856 | CMS |
| Amgen Inc. | $125.93 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117321862 | CMS |
| Amgen Inc. | $26.48 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117623464 | CMS |
| Amgen Inc. | $21.32 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117321858 | CMS |
| Amgen Inc. | $28.55 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117623466 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.78 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123303822 | CMS |
| Currax Pharmaceuticals LLC | $13.95 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089524945 | CMS |
| Lilly USA, LLC | $13.25 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135902840 | CMS |
| Novo Nordisk Inc | $20.00 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108568115 | CMS |
| Novo Nordisk Inc | $15.55 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108567797 | CMS |
| Novo Nordisk Inc | $22.61 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570072 | CMS |
| Novo Nordisk Inc | $14.95 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108573658 | CMS |
| Novo Nordisk Inc | $10.67 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108568049 | CMS |
| Novo Nordisk Inc | $23.73 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108564185 | CMS |
| Novo Nordisk Inc | $18.26 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108569894 | CMS |
| Novo Nordisk Inc | $22.16 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108572892 | CMS |
| Novo Nordisk Inc | $22.04 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108564389 | CMS |
| Novo Nordisk Inc | $23.90 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108568147 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.79 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151186986 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.